Sign In

Kush Parmar, M.D., Ph.D.

Managing Partner at 5AM Ventures

Kush Parmar, M.D., Ph.D., is an accomplished professional with a diverse educational background and extensive experience in the medical, finance, and biotechnology sectors.

He earned his M.D. from Harvard Medical School, a Ph.D. in Biomedical Sciences from Harvard University, and an A.B. in Molecular Biology from Princeton University.

Additionally, Kush Parmar pursued further education in finance at Harvard Business School and completed the M.D., HST Program at the Massachusetts Institute of Technology.

Throughout his career, he has held prominent roles in various organizations, showcasing his leadership and expertise in the industry.

Some of his notable positions include Co-Founder at Immuneel Therapeutics, Ltd., Board Member at Ensoma, Board of Directors at Rallybio, and Chairman of the Board of Directors at Entrada Therapeutics.

His involvement also extends to institutions like Penn Medicine, University of Pennsylvania Health System, where he served as a Research Council Member, and the Department of Molecular Biology at Princeton University, where he was part of the Advisory Council.

Kush Parmar's contributions to the field are further highlighted by his roles at organizations like Grace Science Foundation, 5AM Ventures, Vor Biopharma, Homology Medicines, Inc., and Audentes Therapeutics.

His diverse background and range of appointments underscore his comprehensive understanding of the healthcare, biotechnology, and finance industries, solidifying his reputation as a seasoned professional in the field.

Kush Parmar, M.D., Ph.D.
Add to my network

Location

Boston, Massachusetts, United States